Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 26, 2019 08:30 ET | Source: IES Holdings, Inc.

IES Holdings Announces Fiscal 2019 Third Quarter Results Earnings Release Schedule

HOUSTON, July 26, 2019 (GLOBE NEWSWIRE) -- IES Holdings, Inc. (or “IES”) (NASDAQ: IESC) today announced that it will release fiscal 2019 third quarter results before the market opens on Friday,...
July 26, 2019 08:00 ET | Source: Gentherm Inc.

Gentherm to Participate in the J.P. Morgan Auto Conference

NORTHVILLE, Mich., July 26, 2019 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), the global market leader and developer of innovative thermal management technologies, today announced that Phil Eyler,...
July 26, 2019 08:00 ET | Source: Pacific Mercantile Bancorp

Pacific Mercantile Bancorp to Participate in the 2019 KBW Community Bank Investor Conference

COSTA MESA, Calif., July 26, 2019 (GLOBE NEWSWIRE) -- Pacific Mercantile Bancorp (NASDAQ: PMBC), the holding company of Pacific Mercantile Bank (the “Bank”), a wholly owned banking subsidiary, today...
July 26, 2019 07:00 ET | Source: Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics to Host Second Quarter 2019 Financial Results Conference Call and Webcast on Thursday, August 1, 2019

SAN CARLOS, Calif., July 26, 2019 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on...
July 26, 2019 07:00 ET | Source: uniQure Inc.

uniQure to Participate in Multiple Upcoming Industry Conferences

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, July 26, 2019 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with...
July 26, 2019 06:01 ET | Source: Gemphire Therapeutics Inc.

Gemphire Therapeutics와 NeuroBo Pharmaceuticals, 퇴행성 질환 치료제 개발 위한 통합 법인 설립 위해 합병 합의

Nasdaq 상장사이자 NeuroBo의 임상단계 파이프라인 발전시킬 바이오 기술기업 탄생 NeuroBo, 신경병적 통증 치료 신약 후보 임상3상 시험 예정 NeuroBo, 최근 Series B 파이낸싱 통해 약 2,424만 달러 조달 Gemphire, 중국 시장 겨냥해 Beijing SL Pharmaceutical Co.와Gemcabene에 대한...
July 26, 2019 06:01 ET | Source: Gemphire Therapeutics Inc.

Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease Company

Transaction to Create Nasdaq-listed Biotechnology Company Focused on Advancing NeuroBo’s Clinical-Stage Pipeline NeuroBo Poised to Advance Lead Drug Candidate into Phase 3 Trials for Neuropathic Pain...
July 26, 2019 00:38 ET | Source: T-Mobile US, Inc.

UPDATE: T-Mobile to Host Q2 2019 Earnings Call on July 26, 2019

BELLEVUE, Wash., July 26, 2019 (GLOBE NEWSWIRE) -- T-Mobile US, Inc. (NASDAQ: TMUS) looks forward to discussing its second quarter financial and operational results on Friday, July 26, 2019 at 1:00...
July 25, 2019 18:10 ET | Source: Grupo Hotelero Santa Fe SAB de CV

HOTEL reporta incrementos de 15% en Ingresos Totales y 1% en UAFIDA en el 2T19

CIUDAD DE MÉXICO, July 25, 2019 (GLOBE NEWSWIRE) -- Grupo Hotelero Santa Fe, S.A.B. de C.V. (BMV: HOTEL) (“HOTEL” o “la Compañía”), anunció hoy sus resultados correspondientes al segundo...
July 25, 2019 18:10 ET | Source: Grupo Hotelero Santa Fe SAB de CV

HOTEL reports 15% growth in total revenues and 1% growth in EBITDA for 2Q19

MEXICO CITY, July 25, 2019 (GLOBE NEWSWIRE) -- Grupo Hotelero Santa Fe S.A.B. de C.V. (BMV: HOTEL) (the “HOTEL” or the “Company”), announced its consolidated results for the second quarter (“2Q19”)...